Difficulty: Medium
Average Score: 78%
Practice
Currently used second-generation sulfonylureas include the following EXCEPT:
Correct answer
D
Rationale
In pharmacology, understanding the classification and characteristics of different drug classes is crucial for safe and effective medication management. In the context of second-generation sulfonylureas, it is important to differentiate between the various medications to optimize treatment outcomes for patients with diabetes.
The correct answer is D) Tolbutamide (Orinase) because it is a first-generation sulfonylurea, not a second-generation one. Second-generation sulfonylureas like A) Glyburide (Glibenclamide), B) Glipizide (Glydiazinamide), and C) Glimepiride (Amaril) are preferred over first-generation agents due to their improved potency, duration of action, and reduced risk of hypoglycemia.
Glyburide, glipizide, and glimepiride are commonly used second-generation sulfonylureas in clinical practice. They have a more predictable pharmacokinetic profile, lower risk of drug interactions, and are associated with a lower incidence of hypoglycemia compared to first-generation sulfonylureas like tolbutamide.
Educationally, this question highlights the importance of knowing the specific drugs within a drug class, understanding their differences in pharmacokinetics and pharmacodynamics, and being able to differentiate between generations of medications to make informed clinical decisions. This knowledge is vital for healthcare professionals to provide optimal care for patients with diabetes and ensure safe medication practices.
The correct answer is D) Tolbutamide (Orinase) because it is a first-generation sulfonylurea, not a second-generation one. Second-generation sulfonylureas like A) Glyburide (Glibenclamide), B) Glipizide (Glydiazinamide), and C) Glimepiride (Amaril) are preferred over first-generation agents due to their improved potency, duration of action, and reduced risk of hypoglycemia.
Glyburide, glipizide, and glimepiride are commonly used second-generation sulfonylureas in clinical practice. They have a more predictable pharmacokinetic profile, lower risk of drug interactions, and are associated with a lower incidence of hypoglycemia compared to first-generation sulfonylureas like tolbutamide.
Educationally, this question highlights the importance of knowing the specific drugs within a drug class, understanding their differences in pharmacokinetics and pharmacodynamics, and being able to differentiate between generations of medications to make informed clinical decisions. This knowledge is vital for healthcare professionals to provide optimal care for patients with diabetes and ensure safe medication practices.